Trade Desk Hit Again: HSBC Downgrades to Reduce Target
HSBC downgraded Trade Desk to Reduce with a $20 target, joining a wave of caution as ad-tech faces a shift toward ret...
Which Dividend Aristocrats Etf Did Best In 2024
We compare Which Dividend Aristocrats Etf Did Best In 2024, spotlighting performance leaders and factors behind stronger returns.
23,392 articles
LENZ (LENZ) 2026 Earnings: Q1 Review and Growth Outlook
Investors are keen on LENZ as the company reports Q1 2026 earnings. This in-depth look breaks down the key numbers, w...
Roaring Kitty’s Deleted Post Triggers 90% RKC Crash
A renowned crypto influencer’s deleted post on X set off a chaotic few hours for the Red Kitten Crew meme coin, sendi...
Oklo (OKLO) 2026 Earnings: First Quarter Insights Today
As Oklo enters 2026, the Q1 earnings landscape offers clues about its path to commercialization. This guide breaks do...
Nio Swapped Million Batteries Week: Is NIO Stock a Buy?
Nio just hit a landmark: a swapped million batteries week. The feat showcases its battery-swapping edge, but does it ...
House Spares From Institutional Carve-Outs as Vote Looms Next Week
With a key vote looming, the House offers carve-outs for build-to-rent and renovate-to-rent, altering a broader push ...
Nvidia Stock Hits Highs: Is It Time to Buy?
Nvidia stock hits highs, renewing the debate over whether now is the moment to buy. This guide breaks down what's dri...
Is Evolv Technologies Stock After Lane Generational Buy Worth Considering?
Lane Generational just disclosed a sizeable stake in Evolv Technologies, signaling potential interest from big invest...
DOJ Accuses Yale Discriminating Against Admissions Practices
Federal investigators say Yale's medical school admissions favored certain groups over others, a finding that adds to...
Inside Trump’s Vision America: A Shareholder Model
Trump’s idea to take government stakes in U.S. firms is back in the national conversation, with investors weighing po...
Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Genpact Stock After Hedge: Buy, Hold, or Sell Right Now?
When a hedge fund makes a substantive move in Genpact, it prompts investors to reassess the stock. This article break...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status